Prasugrel NEW
| Price | $35 | $51 | $66 |
| Package | 25mg | 50mg | 100mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-04-30 |
Product Details
| Product Name: Prasugrel | CAS No.: 150322-43-3 |
| Purity: 99.86% | Supply Ability: 10g |
| Release date: 2025/04/30 |
Product Introduction
Bioactivity
| Name | Prasugrel |
| Description | Prasugrel (CS-747) is a piperazine derivative and PLATELET AGGREGATION INHIBITOR that is used to prevent THROMBOSIS in patients with ACUTE CORONARY SYNDROME; UNSTABLE ANGINA and MYOCARDIAL INFARCTION, as well as in those undergoing PERCUTANEOUS CORONARY INTERVENTIONS. |
| In vitro | Prasugrel has a faster, higher and more reliable platelet aggregation inhibitory effect than clopidogrel and is metabolized in vivo to an active metabolite with selective P2Y(12) antagonistic activity. |
| In vivo | Prasugrel has a faster, higher and more reliable platelet aggregation inhibitory effect than clopidogrel and is metabolized in vivo to an active metabolite with selective P2Y(12) antagonistic activity. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 45 mg/mL (120.5 mM), Sonication is recommended. |
| Keywords | Prasugrel | platelet | PCR-4099 | PCR4099 | P2YReceptor | P2Y12 | P2Y Receptor | P2Y | metabolite | LY-640315 | LY 640315 | Inhibitor | inhibit | CS747 | CS 747 | antiplatelet | aggregation | ADP | active |
| Inhibitors Related | Clopidogrel | Prasugrel Hydrochloride | PSB-16133 sodium | Uridine 5′-diphosphoglucose disodium salt | Regrelor disodium | (±) Clopidogrel hydrogen sulfate | Clopidogrel hydrogen sulfate | Uridine-5'-diphosphate disodium salt | N6-(4-Hydroxybenzyl)adenosine | Ticagrelor | Diquafosol tetrasodium | cangrelor tetrasodium |
| Related Compound Libraries | Anti-Neurodegenerative Disease Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | EMA Approved Drug Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $30.00/25mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2025-07-15 | |
| $30.00/25mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2025-07-15 | |
| $/ |
VIP5Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | |
| $1.00/1KG |
VIP7Y
|
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-11-18 | |
| $15.00/1kg |
Ouhuang Engineering Materials (Hubei) Co., Ltd
|
2024-04-24 | ||
| $30.00/1kg |
Anhui Ruihan Technology Co., Ltd
|
2023-08-23 | ||
| $100.00/1kg |
Henan Bao Enluo International TradeCo.，LTD
|
2023-08-01 | ||
| $0.00/25KG |
VIP6Y
|
Hebei Mujin Biotechnology Co.,Ltd
|
2023-06-30 | |
| $1.00/1mg |
ANHUI SHENGZHIKAI BIOTECHNOLOGY CO.,LTD
|
2022-06-20 | ||
| $1.10/1g |
VIP5Y
|
Dideu Industries Group Limited
|
2021-08-04 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, Massachusetts, USA
INQUIRY